Back to search page

rdes20170627001

H2020-MSCA-ITN: Looking for a gene-editing company interested in participating in a project focusing on mobile elements

RESEARCH PROFILE   REQUEST   ADD TO FAVOURITES
PRINT

 

ABSTRACT

A Spanish SME specialised in bioinformatics and computational biology looks for a gene-editing European company wishing to join a research consortium who will apply for the MSCA-ITN-ETN-2018 with a project aimed at studying mobile genetic elements (Life Sciences, LIF panel). They are looking for a company to participate as a beneficiary, and thus to recruit and host an Early-Stage Researcher who will develop a PhD thesis.


FULL DESCRIPTION

The research project will investigate mobile elements under the assumption that transposons, viruses and repeats are all (in one way or another) mobile elements or at least dynamic nucleotide elements, either DNA (DeoxyriboNucleicAcid) or RNA (RiboNucleicAcid). Mobile elements question the genome sequence stability and provide the basis for species adaptation and evolution. They are also of great importance in genetic engineering, since they are powerful tools for genome editing, gene regulation and horizontal gene transfer. They are for instance essential for some popular and well-timed topics such as antibiotic resistance, genetic mutations causing cancer and other diseases, therefore anticipating a potential treatment for these prevalent diseases. Despite their roles, the understanding of mobile elements is still in a very early stage, probably in its infancy.

The research consortium is already composed of a multidisciplinary group of academic and non-academic institutions (9 for the moment) specialised in the research topics of interest, with one of the academic partners studying casposons with the CRISPR genome editing technology angle, which can be programmed to specifically target particular stretches of genetic code and to edit DNA at precise locations, thus allowing researchers to permanently modify genes in living cells and organisms (e.g. to treat genetic diseases).

The Spanish company seeks for a European (EU member state or associated country) company specialised in gene editing, wishing to develop a sub-project within the framework of a European Training Network investigating mobile elements. The gene-editing company will host and supervise an Early-Stage Researcher who will develop a PhD thesis, and will therefore receive funding from the EC and claim for costs (researcher and institutional costs).

Deadline for EoIs: 24th September 2017


Partner expertise sought:

- Specific area of activity of the partner: Type of partner sought. European (EU member state or associated country) R&D company specialised in gene-editing.
Role of partner sought. Beneficiary in a H2020-MSCA-ITN, so to develop a research sub-project in the context of the main project by hosting and supervising an Early Stage Researcher who will develop a PhD at his premises.


Development Stage:

Proposal under development


IPR:

Other

Programme - Call:

Acronym: MObile Genetic Elements as BIOengineering Tools and OMIC ArchitectS for the Evolution of Complex Life (MOBIOMICS)

Website: Not open already. Expected to be open on October 2017 (Scoping Paper for Horizon 2020 work programme 2018-2020 Marie Sklodowska-Curie Actions). Link to the latest call: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topic

Duration: 192 week(s)

Deadline: 02/01/2018

Coordinator required: No

Sign-in or create an account

To express an interest in this profile, you must first sign in or create a new account.

If you already have an account, sign in here

Not got an account yet, sign up here

KEY INFORMATION

Country of origin
SPAIN
Profile date
31/08/2017
Deadline
04/07/2018

PARTNERSHIP(S) SOUGHT

Research cooperation agreement

CLASSIFICATIONS

INDUSTRY SECTORS
Life Sciences \ Biosciences and Health \ Finance, Business & Professional Services \ Recycling & Waste Management \ Drug Discovery and Drug Development \ Diagnostics \ Medical Devices
TECHNOLOGY KEYWORDS
BIOLOGICAL SCIENCES / Medicine, Human Health / Clinical Research, Trials / BIOLOGICAL SCIENCES / Medicine, Human Health / Gene - DNA Therapy / BIOLOGICAL SCIENCES / Medicine, Human Health / Medical Research / BIOLOGICAL SCIENCES / Medicine, Human Health / Medical Technology / Biomedical Engineering / BIOLOGICAL SCIENCES / Genome Research / Gene Expression, Proteome Research
COMMERCIAL KEYWORDS
Research and experimental development on biotechnology / Other professional, scientific and technical activities n.e.c. / Other human health activities
MARKET KEYWORDS
GENETIC ENGINEERING/MOLECULAR BIOLOGY / Recombinant DNA / Medical genetic engineering applications / GENETIC ENGINEERING/MOLECULAR BIOLOGY / Genetic Engineering / GENETIC ENGINEERING/MOLECULAR BIOLOGY / Gene Expression, Proteome Research / GENETIC ENGINEERING/MOLECULAR BIOLOGY / Population genetics / MEDICAL/HEALTH RELATED / Other Medical/Health Related / Other medical/health related (not elsewhere classified)

FIND OUT MORE

Contact Enterprise Europe Network Scotland by email at info@enterprise-europe-scotland.com, quoting reference number rdes20170627001